Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net increase (decrease) in net assets resulting from operations	$ 13,522,659	$ 5,084,659
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net change unrealized (appreciation) depreciation on investments	912,836	(2,336,337)
Net change unrealized (appreciation) depreciation on derivative investments	(11,637)	0
Net change unrealized (appreciation) depreciation on foreign currency and other transactions	10,005
Net realized (gain) loss on investments	(1,658,790)	(203,776)
Net realized (gain) loss on foreign currency and other transactions	1,621	0
Payment-in-kind interest capitalized	(2,157,753)	(1,505,341)
Net accretion of discount and amortization of premium	(3,174,036)	(257,263)
Amortization of deferred financing costs	343,189	133,881
Amortization of offering costs	704,934	246,317
Purchases of investments	(304,246,026)	(303,557,803)
Proceeds from sale of investments and principal repayments	135,054,161	54,570,476
Changes in operating assets and liabilities:
Interest receivable	(2,247,818)	(1,616,559)
Deferred offering costs	(1,187,914)	(142,705)
Receivable for investments sold	(4,163,348)	(11,098,829)
Due from Advisor	575,184	(95,207)
Other assets	(32,935)	(42,081)
Payable for investments purchased	35,316,086	40,902,266
Due to Advisor and affiliates	(38,561)	(920,015)
Management fee payable	209,500	655,299
Income incentive fee payable	364,760	0
Capital gains incentive fee payable	(36,271)	317,514
Interest and credit facility fees payable	773,575	528,514
Accrued expenses and other liabilities	420,695	741,466
Net cash provided by (used in) operating activities	(130,745,884)	(218,595,524)
Cash flows from financing activities:
Proceeds from Secured Credit Facility	60,000,000	13,500,000
Deferred financing costs paid	0	(1,195,091)
Dividends paid in cash	(7,464,682)	(102,893)
Proceeds from issuance of common shares	104,522,157	208,177,000
Net cash provided by (used in) financing activities	157,057,475	220,379,016
Net increase (decrease) in cash and cash equivalents	26,311,591	1,783,492
Cash, cash equivalents and restricted cash, beginning of period	73,025,293	10,000
Cash, cash equivalents and restricted cash, end of period	99,336,884	1,793,492
Supplemental information and non-cash activities:
Cash paid for interest	10,230,126	0
Reinvestment of distributions	13,125,543	3,037,048
Accrued but unpaid deferred offering cost	$ 145,282	$ 216,950